Fibrinolytic properties of a human endothelial hybrid cell line (EA.hy 926)
article
The fibrinolytic characteristics of the endothelial hybrid cell line EA.hy 926, established by fusing a human umbilical vein endothelial cell with a human carcinoma cell line, were studied. The hybrid cell line produced large amounts of tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor type 1, and a small amount of urokinase. All plasminogen activator present in conditioned medium was complexed with inhibitor because the cells secreted plasminogen activator inhibitor in excess over plasminogen activator and no activator activity was detectable in conditioned media by direct activity assays. t-PA activator activity was, however, demonstrable in conditioned media after treatment with sodium dodecyl sulfate, in agreement with t-PA antigen determinations. Increased plasminogen activator inhibited activity could be induced by incubating the cells in the presence of endotoxin or microtubule inhibitors, whereas increased t-PA activity could be induced by microtubule inhibitors. Interleukin-1 had no effect. The fibrinolytic characteristics of the hybrid cell line were stable for at least 30 passages. The perpetual human hybrid cell line EA.hy926 therefore may be a useful tool for the study of fibrinolysis in cultured endothelial cells. Chemicals/CAS: tissue plasminogen activator, 105913-11-9; Colchicine, 64-86-8; Endotoxins; Glycoproteins; Interleukin-1; Plasminogen Inactivators; Tissue Plasminogen Activator, EC 3.4.21.68; Vinblastine, 865-21-4
Topics
TNO Identifier
230635
ISSN
00064971
Source
Blood, 71(6), pp. 1669-1675.
Pages
1669-1675
Files
To receive the publication files, please send an e-mail request to TNO Repository.